Most polymers begin with petroleum. Ours begin with the ocean.
Our proprietary process enables us to produce consistent, high-purity biomaterials at the volume industrial buyers require.
The MCE platform
We transform shellfish byproducts through our proprietary MCE process into high-purity materials at production scale.
This proprietary process combines mechanical preparation, a citric-acid chemical stage and organic enzymes rather than conventional hydrochloric acid and sodium hydroxide, enabling cleaner, high-purity and consistent biomaterial output.
Our biomaterials
Carbonized chitin
Chitosan hemostatic
Derivatives & nanocrystals
Chitin
Chitosan
Our circular production
1. High quality Atlantic shell feedstock
2. MCE process platform
3. Advanced marine biopolymer materials
4. Priority pathways and end market
Key differentiators
Atlantic marine byproducts
Industrial infrastructure and feedstock control
Multiple product pathways
Canadian IP and production
Industrial applications
-
Medical & Pharma
-
Defence & Emergency response
-
Energy
-
Aquaculture
-
Advanced materials & Textile manufacturers